Table 4 Multiple linear regression analysis of factors influencing total PANSS scores in patients.

From: The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation

Variable

b

SE b

β

t

P

95% CI

ACSL4 (ng/mL)

0.16

0.26

0.04

0.62

0.535

[āˆ’0.348, 0.667]

GPX4 (ng/mL)

āˆ’0.53

0.35

āˆ’0.11

āˆ’1.52

0.129

[āˆ’1.223, 0.157]

GSH (g/L)

āˆ’1.08

0.49

āˆ’0.15

āˆ’2.19

0.030

[āˆ’2.057, āˆ’0.107]

FE (ng/mL)

5.23

3.26

0.11

1.60

0.110

[āˆ’1.203, 11.672]

Iron (μmol/L)

āˆ’0.06

0.03

āˆ’0.13

āˆ’2.04

0.043

[āˆ’0.125, āˆ’0.002]

TF (mg/mL)

āˆ’1.44

1.01

āˆ’0.10

āˆ’1.42

0.157

[āˆ’3.428, 0.556]

SOD (U/mL)

0.33

0.13

0.17

2.46

0.015

[0.065, 0.592]

MDA (nmol/mL)

0.57

0.48

0.09

1.19

0.234

[āˆ’0.371, 1.507]

  1. PANSS positive and negative syndrome scale, ACSL4 acyl-CoA synthase long-chain family member 4, GPX4 glutathione peroxidase 4, GSH glutathione, FE ferritin, TF transferrin, SOD superoxide dismutase, MDA malondialdehyde.
  2. b Means unstandardized regression coefficient; B means standardized regression coefficient.
  3. R2 = 0.193, adjusted R2 = 0.160, F = 5.825, P < 0.001.